Live Quote · NASDAQCGENHealthcare· Biotechnology

Compugen Ltd.

$2.28 7.04%(+$0.15)
TickerSpark Score
81/100
Strong
80
Valuation
100
Profitability
100
Growth
64
Health
60
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CGEN research report →

52-Week Range51% of range
Low
$1.30
Current
$2.28
High
$3.24
Company Overviewcgen.com

About the company

Compugen Ltd. , an Israeli-based company established in 1993 and headquartered in Holon, is a clinical-stage enterprise focused on the discovery, development, and commercialization of therapeutic and product candidates. Its operations extend across Israel, the United States, and Europe.

CEO
Eran Ophir
IPO
2000
Employees
74
HQ
Holon, IL

Price Chart

+31.03% · this period
$3.10$2.21$1.33Jul 02Dec 31Jul 02
Valuation
Market Cap
$215.58M
P/E
6.21
P/S
2.97
P/B
2.26
EV/EBITDA
5.91
Div Yield
0.00%
Profitability
Gross Margin
88.06%
Op Margin
42.26%
Net Margin
47.97%
ROE
47.72%
ROIC
24.67%
Growth & Income
Revenue
$72.76M · 161.14%
Net Income
$35.34M · 348.35%
EPS
$0.38 · 337.50%
Op Income
$31.33M
FCF YoY
-36.69%
Performance & Tape
52W High
$3.24
52W Low
$1.30
50D MA
$2.47
200D MA
$2.00
Beta
2.77
Avg Volume
502.75K

Get TickerSpark's AI analysis on CGEN

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Apr 24, 26Levine Zuritother2,000
Apr 24, 26Levine Zuritother2,000
Apr 24, 26Levine Zuritsell2,000
Apr 24, 26Ophir Eranother5,000
Apr 24, 26Ophir Eranother5,000
Apr 24, 26Ophir Eransell5,000
Apr 14, 26Ophir Eranother5,000
Apr 14, 26Ophir Eranother5,000
Apr 14, 26Ophir Eransell5,000
Apr 14, 26Levine Zuritother2,000
Coverage · CGEN

Our CGEN coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on CGEN yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate CGEN report →
Internal Compare

Similar companies

Peers in the same neighborhood.